We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.71B
AUM Growth
-$105M
Cap. Flow
-$29.7M
Cap. Flow %
-1.1%
Top 10 Hldgs %
23.72%
Holding
332
New
19
Increased
70
Reduced
176
Closed
23

Top Buys

Rank Stock Value
1
GXO icon
GXO Logistics
GXO
+$23.9M
2
SNBR
Sleep Number
SNBR
+$17.4M
3
BBBY
Bed Bath & Beyond
BBBY
+$7.08M
4
IAA
IAA, Inc. Common Stock
IAA
+$5.96M
5
BVS icon
Bioventus
BVS
+$5.71M

Top Sells

Rank Stock Value
1
XPO icon
XPO
XPO
+$20.8M
2
ZD icon
Ziff Davis
ZD
+$9.39M
3
NKTR icon
Nektar Therapeutics
NKTR
+$8.49M
4
POOL icon
Pool Corp
POOL
+$7.21M
5
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$7.06M

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 24.54%
3 Industrials 15.71%
4 Consumer Discretionary 13.79%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCO icon
251
Moody's
MCO
$82.8B
$840K 0.03%
2,366
– –
HAS icon
252
Hasbro
HAS
$13.3B
$757K 0.03%
8,481
-657
-7% -$63.8K
ABBV icon
253
AbbVie
ABBV
$438B
$753K 0.03%
6,977
-300
-4% -$34.3K
IWO icon
254
iShares Russell 2000 Growth ETF
IWO
$14.9B
$698K 0.03%
2,377
+755
+47% +$227K
LLY icon
255
Eli Lilly
LLY
$1.1T
$552K 0.02%
2,390
– –
CAG icon
256
Conagra Brands
CAG
$7.07B
$521K 0.02%
15,377
-478
-3% -$16.2K
CVX icon
257
Chevron
CVX
$382B
$471K 0.02%
4,643
– –
J icon
258
Jacobs Solutions
J
$17.2B
$470K 0.02%
4,286
– –
MRK icon
259
Merck
MRK
$323B
$457K 0.02%
6,084
-428
-7% -$32.6K
PG icon
260
Procter & Gamble
PG
$340B
$456K 0.02%
3,264
– –
PEP icon
261
PepsiCo
PEP
$188B
$452K 0.02%
3,007
-200
-6% -$31K
SYY icon
262
Sysco
SYY
$40.1B
$450K 0.02%
5,727
-800
-12% -$61K
GO icon
263
Grocery Outlet
GO
$972M
$431K 0.02%
20,000
-90,397
-82% -$2.6M
WMT icon
264
Walmart Inc
WMT
$897B
$427K 0.02%
9,198
– –
BRK.A icon
265
Berkshire Hathaway Class A
BRK.A
$1.14T
$411K 0.02%
1
– –
NMRK icon
266
Newmark Group
NMRK
$2.52B
$410K 0.02%
28,634
– –
SYNA icon
267
Synaptics
SYNA
$4.09B
$375K 0.01%
2,088
– –
JPM icon
268
JPMorgan Chase
JPM
$956B
$368K 0.01%
2,249
– –
INTC icon
269
Intel
INTC
$492B
$362K 0.01%
6,801
– –
JLL icon
270
Jones Lang LaSalle
JLL
$16.4B
$357K 0.01%
1,440
– –
ENOV icon
271
Enovis
ENOV
$1.4B
$350K 0.01%
4,430
– –
AMZN icon
272
Amazon
AMZN
$3T
$348K 0.01%
2,120
– –
WDFC icon
273
WD-40
WDFC
$3.15B
$336K 0.01%
1,450
– –
AMN icon
274
AMN Healthcare
AMN
$1.42B
$331K 0.01%
2,888
– –
COHR
275
DELISTED
Coherent Inc
COHR
$311K 0.01%
+1,244
New +$312K
9 10
11
12 13

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Rice Hall James & Associates held 332 positions worth $2.71B, down 3.7% from $2.81B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q3 2021 filing shows 19 new, 70 increased, 176 reduced and 23 closed positions. Its largest new stake was GXO Logistics: 305,297 shares worth $23.9M. The largest sale was XPO, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q3 2021 buy was GXO Logistics: 305,297 shares worth $23.9M.
  • Rice Hall James & Associates added most to Bed Bath & Beyond in Q3 2021, an estimated $7.08M increase.
  • Rice Hall James & Associates's biggest Q3 2021 reduction was XPO, cutting an estimated $20.8M.
  • Rice Hall James & Associates fully exited Nektar Therapeutics in Q3 2021, selling an estimated $8.49M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.71B portfolio in Q3 2021.
  • Rice Hall James & Associates opened 19 new positions and closed 23 in Q3 2021.
  • Rice Hall James & Associates's portfolio value fell 3.7% quarter-over-quarter to $2.71B.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.